Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · IEX Real-Time Price · USD
1.050
+0.010 (0.96%)
At close: Jul 19, 2024, 4:00 PM
0.950
-0.100 (-9.52%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Cytosorbents Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2006
Revenue
36.6936.3534.6943.174124.95
Upgrade
Revenue Growth (YoY)
3.50%4.79%-19.64%5.27%64.35%10.87%
Upgrade
Cost of Revenue
13.1813.9613.9611.0511.057.36
Upgrade
Gross Profit
23.5122.3920.7332.1229.9517.59
Upgrade
Selling, General & Admin
37.9237.8737.1438.4831.5124.47
Upgrade
Research & Development
13.7615.7315.1216.388.8112.09
Upgrade
Operating Expenses
51.6853.652.2554.8640.3236.56
Upgrade
Operating Income
-28.18-31.21-31.52-22.74-10.37-18.97
Upgrade
Interest Expense / Income
0.10.16-0.13-0.031.21.03
Upgrade
Other Expense / Income
0.08-2.052.522.58-2.610.35
Upgrade
Pretax Income
-28.35-29.32-33.91-25.29-8.96-20.36
Upgrade
Income Tax
-0.81-0.81-1.09-0.74-1.13-1.09
Upgrade
Net Income
-27.54-28.51-32.81-24.56-7.84-19.27
Upgrade
Shares Outstanding (Basic)
544544433932
Upgrade
Shares Outstanding (Diluted)
544544433932
Upgrade
Shares Change
24.24%2.49%0.49%11.70%20.35%5.00%
Upgrade
EPS (Basic)
-0.59-0.64-0.75-0.57-0.20-0.60
Upgrade
EPS (Diluted)
-0.59-0.64-0.75-0.57-0.20-0.60
Upgrade
Free Cash Flow
-23.45-22.19-34.32-17.65-6.32-17.46
Upgrade
Free Cash Flow Per Share
-0.43-0.50-0.79-0.41-0.16-0.54
Upgrade
Gross Margin
64.08%61.60%59.77%74.41%73.05%70.48%
Upgrade
Operating Margin
-76.80%-85.86%-90.87%-52.69%-25.29%-76.05%
Upgrade
Profit Margin
-75.07%-78.43%-94.59%-56.89%-19.11%-77.22%
Upgrade
Free Cash Flow Margin
-63.92%-61.06%-98.94%-40.88%-15.42%-69.97%
Upgrade
EBITDA
-26.1-27.14-32.91-24.19-7.1-18.74
Upgrade
EBITDA Margin
-71.13%-74.65%-94.86%-56.05%-17.32%-75.12%
Upgrade
Depreciation & Amortization
2.162.031.131.130.660.58
Upgrade
EBIT
-28.25-29.16-34.04-25.32-7.76-19.32
Upgrade
EBIT Margin
-77.01%-80.23%-98.12%-58.66%-18.93%-77.45%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).